Epstein Secrets

ing day after the public announcement of the acquisition, the price of Valspar stock increased approximately 23 percent over the prior day's close. Millul, a Manhattan jeweler opened a brokerage account on March 13, 2016, and shortly thereafter purchased 480 shares of Valspar common stock, case records

ceutical distributors in the United States. Charges were also filed against Laurence F. Doud III, the company's former chief executive officer; and William Pietruszewski, the company's former chief compliance officer. The indictment was specifically for "unlawfully distributing oxycodone and fentanyl, and conspiring

he public announcement of the acquisition, the price of Valspar stock increased approximately 23 percent over the prior day's close. EFTA00085700 Millul, a Manhattan jeweler opened a brokerage account on March 13, 2016, and shortly thereafter purchased 480 shares of Valspar common stock, case records

ceutical distributors in the United States. Charges were also filed against Laurence F. Doud III, the company's former chief executive officer; and William Pietruszewski, the company's former chief compliance officer. The indictment was specifically for "unlawfully distributing oxycodone and fentanyl, and conspiring

ing day after the public announcement of the acquisition, the price of Valspar stock increased approximately 23 percent over the prior day's close. Millul, a Manhattan jeweler opened a brokerage account on March 13, 2016, and shortly thereafter purchased 480 shares of Valspar common stock, case records

announced, Millul also purchased 75 out-of-the-money Valspar call options, according to case records. After the acquisition was publicly announced, Millul sold his Valspar stock and options for approximately $106,806 in profits, Berman said. Oujaddou, a Manhattan hairstylist and salon owner who has kn

ceutical distributors in the United States. Charges were also filed against Laurence F. Doud III, the company's former chief executive officer; and William Pietruszewski, the company's former chief compliance officer. The indictment was specifically for "unlawfully distributing oxycodone and fentanyl, and conspiring